Clinical Trial: Bioavailability and Bioequivalence Study of Extended Release Torsemide and Spironolactone
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Bioavailability Heathy Volunteers
Study Type: INTERVENTIONAL
Official Title: Bioavailability and Bioequivalence (BA/BE) Study of Extended Release (ER) Torsemide and Spironolactone Fixed Dose Combination (FDC) Tablet in Healthy Adult Human Subjects
Brief Summary:
To study intrasubject variability and steady-state pharmacokinetics of multiple-doses of Extended Release Torsemide and Spironolactone Fixed Dose Combination (FDC) tablets given together in healthy adult subjects.
Read more